Perigon Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,058	Closed	-$274K	–	1316
2025 Q3	$274K	Buy	+5,058	New	+$289K	0.01%	1011
2021 Q2	–	Sell	-4,444	Closed	-$336K	–	516
2021 Q1	$336K	Buy	4,444 +3,695	+493%	+$302K	0.03%	366
2020 Q4	$66K	Buy	+749	New	+$59.4K	0.01%	656
2019 Q3	–	Sell	-2,709	Closed	-$232K	–	244
2019 Q2	$232K	Hold	2,709	–	–	0.05%	212
2019 Q1	$231K	Hold	2,709	–	–	0.05%	196
2018 Q4	$259K	Hold	2,709	–	–	0.07%	175
2018 Q3	$263K	Sell	2,709 -452	-14%	-$45.1K	0.06%	191
2018 Q2	$298K	Buy	+3,161	New	+$277K	0.09%	183
2017 Q4	–	Sell	-2,169	Closed	-$202K	–	610
2017 Q3	$202K	Sell	2,169 -4,137	-66%	-$366K	0.07%	198
2017 Q2	$573K	Buy	6,306 +330	+6%	+$30K	0.12%	160
2017 Q1	$525K	Buy	5,976 +811	+16%	+$72.2K	0.11%	173
2016 Q4	$485K	Buy	5,165 +506	+11%	+$43.5K	0.11%	179
2016 Q3	$431K	Buy	4,659 +536	+13%	+$50.5K	0.11%	156
2016 Q2	$321K	Buy	+4,123	New	+$351K	0.09%	167